| Literature DB >> 25211073 |
Thomas B Kepler1, Hua-Xin Liao2, S Munir Alam2, Rekha Bhaskarabhatla3, Ruijun Zhang2, Chandri Yandava3, Shelley Stewart2, Kara Anasti2, Garnett Kelsoe4, Robert Parks2, Krissey E Lloyd2, Christina Stolarchuk2, Jamie Pritchett2, Erika Solomon2, Emma Friberg2, Lynn Morris5, Salim S Abdool Karim6, Myron S Cohen7, Emmanuel Walter8, M Anthony Moody8, Xueling Wu9, Han R Altae-Tran9, Ivelin S Georgiev9, Peter D Kwong9, Scott D Boyd10, Andrew Z Fire10, John R Mascola9, Barton F Haynes11.
Abstract
Induction of HIV-1 broad neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development but has remained challenging partially due to unusual traits of bnAbs, including high somatic hypermutation (SHM) frequencies and in-frame insertions and deletions (indels). Here we examined the propensity and functional requirement for indels within HIV-1 bnAbs. High-throughput sequencing of the immunoglobulin (Ig) VHDJH genes in HIV-1 infected and uninfected individuals revealed that the indel frequency was elevated among HIV-1-infected subjects, with no unique properties attributable to bnAb-producing individuals. This increased indel occurrence depended only on the frequency of SHM point mutations. Indel-encoded regions were generally proximal to antigen binding sites. Additionally, reconstruction of a HIV-1 CD4-binding site bnAb clonal lineage revealed that a large compound VHDJH indel was required for bnAb activity. Thus, vaccine development should focus on designing regimens targeted at sustained activation of bnAb lineages to achieve the required SHM and indel events.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25211073 PMCID: PMC4163498 DOI: 10.1016/j.chom.2014.08.006
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023